Contact
Suggestions, questions, or needs? Email us at info@drugsafetyhub.com and we’ll get back to you shortly. Thanks for your feedback and ideas.
About us:
The DrugSafetyHub blog aims to foster an open industry exchange on the subject of diverted and counterfeit prescription drugs in the pharmaceutical supply chain and the safety threats they pose to patients and consumers. In addition to shining a light on the problem, we seek to create an independent forum for solutions. DrugSafetyHub is a place where experts, advocates and consumers can share information and ideas – and outrage when necessary – in the service of fueling needed change.
About | Contributors | Blog Policy
Recent Event: April 3 Webinar
California Board of Pharmacy March 25 meeting Recap
This recorded webinar with Dr. Paul Rudolf reviews the decisions made at the California Board of Pharmacy’s March 25, 2008 meeting in San Diego, discusses federal initiatives, and offers industry implications and recommendations.
Register to access the notes and recording.
Notable + Quotable:
Counterfeiting drugs is a big business. The Centre for Medicines in the Public Interest has predicted that counterfeit drug sales could nearly double to $75 billion by 2010.
Brought to you by:
DrugSafetyHub is sponsored by SupplyScape, produced by Beeline Labs, and editorially managed by Corante.